TY  - GEN
N2  - This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
DO  - 10.1007/978-3-319-78238-6
DO  - doi
AB  - This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
T1  - Resistance to ibritumomab in lymphoma /
AU  - Hosono, Makoto,
AU  - Chatal, Jean-François,
VL  - volume 18
CN  - RC280.L9
ID  - 838796
KW  - Lymphomas
KW  - Drug resistance in cancer cells.
SN  - 9783319782386
SN  - 331978238X
TI  - Resistance to ibritumomab in lymphoma /
LK  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-78238-6
UR  - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-78238-6
ER  -